close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

JNJ

230.7

+1.46%↑

ISRG

498.28

-1.06%↓

ABT

109.51

+0.26%↑

RDY

13.54

+1.04%↑

NEOG

10.22

+0.1%↑

JNJ

230.7

+1.46%↑

ISRG

498.28

-1.06%↓

ABT

109.51

+0.26%↑

RDY

13.54

+1.04%↑

NEOG

10.22

+0.1%↑

JNJ

230.7

+1.46%↑

ISRG

498.28

-1.06%↓

ABT

109.51

+0.26%↑

RDY

13.54

+1.04%↑

NEOG

10.22

+0.1%↑

JNJ

230.7

+1.46%↑

ISRG

498.28

-1.06%↓

ABT

109.51

+0.26%↑

RDY

13.54

+1.04%↑

NEOG

10.22

+0.1%↑

JNJ

230.7

+1.46%↑

ISRG

498.28

-1.06%↓

ABT

109.51

+0.26%↑

RDY

13.54

+1.04%↑

NEOG

10.22

+0.1%↑

Home・Aandelen Lijst・MiNK Therapeutics
Search

MiNK Therapeutics

Gesloten

11.42 -2.64

Buy

Prijsupdate 2 feb 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

11.09

Max

11.6

Belangrijke statistieken

By Trading Economics

Inkomsten

1.4M

-2.9M

EPS

-0.65

Werknemers

23

EBITDA

1.3M

-2.8M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+197.11% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2.3M

60M

Vorige openingsprijs

14.06

Vorige sluitingsprijs

11.42

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

7.81 / 8.1 Steun & Weerstand

MiNK Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 feb 2026, 23:59 UTC

Marktinformatie

Oil Prices Fall Amid Signs of U.S.-Iran Negotiations -- Market Talk

DJ

Lezen

1 feb 2026, 23:47 UTC

Marktinformatie

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

DJ

Lezen

1 feb 2026, 23:44 UTC

Marktinformatie

Gold Falls as Markets Further Price in Warsh-Led Fed -- Market Talk

DJ

Lezen

1 feb 2026, 12:47 UTC

Acquisities, Fusies, Overnames

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion -- Update

DJ

Lezen

1 feb 2026, 03:02 UTC

Acquisities, Fusies, Overnames

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion

DJ

Lezen

1 feb 2026, 03:01 UTC

Acquisities, Fusies, Overnames

KKR Consortium Currently Owns Near 20% Stake in STT GDC

DJ

Lezen

1 feb 2026, 03:01 UTC

Acquisities, Fusies, Overnames

KKR Consortium Acquiring Remaining Stake in STT GDC With Singtel, Sources Say

DJ

Lezen

31 jan 2026, 18:48 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- Update

DJ

Lezen

31 jan 2026, 16:40 UTC

Winsten

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

DJ

Lezen

31 jan 2026, 09:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:41 UTC

Marktinformatie

Deckers Outdoor Seen as Undervalued -- Market Talk

DJ

Lezen

30 jan 2026, 23:12 UTC

Acquisities, Fusies, Overnames

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

DJ

Lezen

30 jan 2026, 22:20 UTC

Winsten

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

DJ

Lezen

30 jan 2026, 22:10 UTC

Marktinformatie

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

DJ

Lezen

30 jan 2026, 21:36 UTC

Winsten

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

DJ

Lezen

30 jan 2026, 21:33 UTC

Winsten

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

DJ

Lezen

30 jan 2026, 20:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

DJ

Lezen

30 jan 2026, 20:37 UTC

Acquisities, Fusies, Overnames

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

DJ

Lezen

Peer Vergelijking

Prijswijziging

MiNK Therapeutics Prognose

Koersdoel

By TipRanks

197.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 35 USD  197.11%

Hoogste 35 USD

Laagste 35 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor MiNK Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan MiNK Therapeutics - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

7.81 / 8.1Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Lange Termijn

Bearish Evidence

There is one bearish event.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

230.7

↑ +1.46%

ISRG

Intuitive Surgical Inc

498.28

↓-1.06%

ABT

Abbott Laboratories

109.51

↑ +0.26%

RDY

Dr Reddy's Laboratories Ltd-ADR

13.54

↑ +1.04%

NEOG

Neogen Corp

10.22

↑ +0.1%
help-icon Live chat